Sofiderm is a full product line of hyaluronic acid gel including Sofiderm® cross-linked dermal filler and Sofiderm®Meso.

Sofiderm® cross-linked injectable dermal fillers are formulated with MCLPE Technology–creating a broad range of HA gel textures and particle sizes with different lifting capacities, enabling your health-care practitioner to tailor a treatment to your specific and unique needs precisely.

Sofiderm@Meso offers a Meso therapy to provide natual-looking results and reveal a younger-looking you.

Sodiderm® dermal fillers can be used to enhance facial contours such as the treatment for cleft lip and eyelid malposition, nose deformity, and facial lipoatrophy.

Sofiderm®Meso are new-generation revitalization products designed to improve skin smoothness, rejuvenate skin, and treat hair problems etc.

Only healthcare professionals trained in Sofiderm injections are qualified to administer it. This may include plastic surgeons, cosmetic clinicians, dermatologists or aesthetic nurses depending on the local legislation.

Patients with a known allergy to hyaluronic acid based products should not undergo treatment, nor should patients with bleeding disorders, or active skin disease such as inflammation, infection or tumors in or near the area to be treated. Discuss contraindications, warnings and precautions with your healthcare practitioner before Sofiderm treatment.

As Sofiderm is a non-permanent injectable product, it will degrade gradually in the body, treatment effect may vary depending on treatments areas, age, activity level and injection dose. Please consult the practitioner for detailed information in order to maintain the aesthetic result, and top-up treatments are recommended.

Within the first 24 hours, patients should avoid makeup, strenuous exercise, extensive sun or heat exposure, and alcoholic beverages. Exposure to any of the above may cause temporary redness, swelling, and/or itching at the injection sites.

Since Sodiferm treatments are clinically proven for gradually improving facial conditions, it is recommended to have touch up treatment for maintaining the results achieved in the initial treatment. Touch-up treatments will most likely require lower volumes of Sofiderm, depending on the injecting area and the time gaps between the treatments.

The most common side effects include treatment site reactions such as swelling, bruising, pain or tenderness, discoloration/hyperpigmentation, redness, itching, lumps. In most cases, symptoms were of mild to moderate intensity and resolved in 7 days or less. Other potential side effects can occur with dermal filler or Meso injections. You should discuss the potential treatment risks with your health-care practitioner.

For sodiferm cross-linked dermal fillers, you will see results immediately after the injection

For Sofiderm Meso therapy, it takes 1-3 months (several sessions accordingly) to see the results.

Sofiderm is manufactured by Techderm, a professional manufacturer of hyaluronic acid, specializes in dermatology and is present in more than 30 countries. To read more about Techderm, please visit: